Intravenous infusion of dexmedetomidine can prevent the degeneration of spinal ventral neurons induced by intrathecal morphine after a noninjurious interval of spinal cord ischemia in rats

Anesthesia and Analgesia

Volumn 105, Issue 4, 2007, Pages 1086-1093

  Kakinohana, Manabu ^a   Oshiro, Masakatsu ^a   Saikawa, Satoko ^a   Nakamura, Seiya ^a   Higa, Tatsuya ^a   Davison, Kenneth J ^a   Marsala, Martin ^a   Sugahara, Kazuhiro ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; HISTOPATHOLOGY; MALE; MOTOR PERFORMANCE; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RATING SCALE; SEDATION; SPASTIC PARAPLEGIA; SPINAL CORD; SPINAL CORD ISCHEMIA; SPINAL CORD NERVE CELL; SPINAL CORD VENTRAL HORN; STATISTICAL SIGNIFICANCE;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; ANTERIOR HORN CELLS; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; INJECTIONS, SPINAL; MALE; MORPHINE; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD ISCHEMIA;

EID: 34748926978     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000278641.90190.8d     Document Type: Article

References (28)

1. Chaney MA. High-dose intrathecal morphine for thoracoabdominal aneurysm repair. J Cardiothorac Vasc Anesth 1996;10:306-7
2. Kakinohana M, Marsala M, Carter C, Davison KJ, Yaksh TL. Neuraxial morphine may trigger transient spasticity after a non-injurious interval of spinal cord ischemia: a clinical and experimental study. Anesthesiology 2003;98:862-70
3. Kakinohana M, Fuchigami T, Nakamura S, Sasara T, Kawabata T, Sugahara K. Intrathecal administration of morphine, but not small dose, induced spastic paraparesis after a noninjurious interval of aortic occlusion in rats. Anesth Analg 2003;96:769-75
4. Fuchigami T, Taira Y, Kakinohana M, Kakinohana O, Iha H, Okuda Y. Repetitive intrathecal administration of morphine induces irreversible paraplegia after non-injurious interval of spinal cord ischemia in the rat. Biologia 1999;54:51-60
5. Acher CW, Wynn MM. Multifactoral nature of spinal cord circulation. Semin Thorac Cardiovasc Surg 1998;10:7-10
6. Kofke WA, Garman RH, Tom WC, Rose ME, Hawkins RA. Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain. Anesth Analg 1992;75:953-64
7. Kofke WA, Garman RH, Stiller RL, Janosky J, Rose ME. Opioid neurotoxicity: fentanyl dose response effects in rats. Anesth Analg 1996;83:1298-306
8. Kofke WA, Attaallah AF, Kuwabara H, Garman RH, Sinz EH, Barbaccia J, Gupta N, Hogg JP. The neuropathologic effects in rats and neurometabolic effect in humans of large-dose remifentanil. Anesth Analg 2002;94:1229-36
9. Kofke WA, Garman RH, Garman R, Rose M. Opioid neurotoxicity: role of neurotoransmitter system. Neurol Res 2000;22:733-7
10. Kakinohana M, Kakinohana O, Jun HJ, Davison KJ, Marsala M, Sugahara K. The activation of spinal N-methyl-D-aspartate receptors may contribute to degeneration of spinal motor neurons induced by neuraxial morphine after a noninjurous interval of spinal cord ischaemia. Anesth Analg 2005;100:327-34
11. Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology 2000;93:1345-9
12. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705
13. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatients surgery. Anesth Analg 2004;98:153-8
14. Kuhmonen J, Polorny J, Miettinen R, Haapalinna A, Jolkkonen J, Riekkinen P Sr, Sivenius J. Neuroprotective effects of dexmedetomidine in the geribil hippocampus following transient global ischemia. Anesthesiology 1997;87:371-7
15. Maier C, Steinberg GK, Sun GH, Zhi GT, Maze M. Neuroprotection by the α2-adrenoreceptor agonist dexmedetomidine in a gocal model of cerebral ischemia. Anesthesiology 1993;79:1-7
16. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Anesthesiology 1991;75:328-32
17. Bickler PE, Hansen BM. Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia. Neuropharmacology 1996;35:679-87
18. Talke P, Bickler PE. Effects of dexmedetomidine on hypoxiaevoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology 1996;85:551-7
19. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031-6
20. Taira Y, Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 1996;27:1850-8
21. Kakinohana M, Taira Y, Marsala M. The effect of graded postischemic spinal cord hypothermia on neurological outcome and histopathology after transient spinal ischaemia in rat. Anesthesiology 1999;90:789-98
22. Dowlatshahi P, Yaksh TL. Differential effects of two intraventricularly injected alpha 2 agonists, ST-91 and dexmedetomidine, on electroencephalogram, feeding, and electromyogram. Anesth Analg 1997;84:133-8
23. Ting P, Xu S, Krumins S. Endogeneous opioid system activity following temporary focal cerebral ischaemia. Acta Neurochir Suppl 1994;60:253-6
24. Curtis DR, Duggan AW. The depression of spinal inhibition by morphine. Agents Actions 1969;1:14-19
25. Werz MA, Macdonald RL. Opiate alkaloids antagonized postsynaptic glycine and GABA responces: correlation with convulsant action. Brain Res 1982;236:107-19
26. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987;7:369-79
27. Sombati S, Culter DA, DeLorenzo RJ. Neurotoxic activation of glutamate receptors induces an extended, neuronal depolarization in cultured hippocampal neurons. Brain Res 1991;566:316-19
28. Honda M, Sekiguchi Y, Sato N, Ono H. Involvement of imidazoline receptors in the centrally acting muscle-relazant effects of tizanidine. Eur J Pharmacol 2002;445:187-93